ACADIA Pharmaceuticals, Inc. (ACAD)
20.57
+0.10
(+0.49%)
USD |
NASDAQ |
Nov 03, 16:00
20.57
0.00 (0.00%)
After-Hours: 16:15
ACADIA Pharmaceuticals Cash and Short Term Investments (Quarterly) : 956.47M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 956.47M |
| March 31, 2026 | 851.46M |
| December 31, 2025 | 819.69M |
| September 30, 2025 | 847.02M |
| June 30, 2025 | 762.00M |
| March 31, 2025 | 681.58M |
| December 31, 2024 | 755.99M |
| September 30, 2024 | 565.33M |
| June 30, 2024 | 500.94M |
| March 31, 2024 | 470.52M |
| December 31, 2023 | 438.86M |
| September 30, 2023 | 345.92M |
| June 30, 2023 | 375.38M |
| March 31, 2023 | 402.87M |
| December 31, 2022 | 416.82M |
| September 30, 2022 | 436.58M |
| June 30, 2022 | 436.35M |
| March 31, 2022 | 445.98M |
| December 31, 2021 | 520.71M |
| September 30, 2021 | 540.29M |
| June 30, 2021 | 556.92M |
| March 31, 2021 | 577.77M |
| December 31, 2020 | 631.96M |
| September 30, 2020 | 644.44M |
| June 30, 2020 | 658.55M |
| Date | Value |
|---|---|
| March 31, 2020 | 651.41M |
| December 31, 2019 | 697.43M |
| September 30, 2019 | 683.85M |
| June 30, 2019 | 381.89M |
| March 31, 2019 | 414.32M |
| December 31, 2018 | 473.52M |
| September 30, 2018 | 214.14M |
| June 30, 2018 | 256.86M |
| March 31, 2018 | 298.06M |
| December 31, 2017 | 341.34M |
| September 30, 2017 | 366.62M |
| June 30, 2017 | 417.32M |
| March 31, 2017 | 469.48M |
| December 31, 2016 | 529.04M |
| September 30, 2016 | 588.86M |
| June 30, 2016 | 412.56M |
| March 31, 2016 | 457.24M |
| December 31, 2015 | 215.13M |
| September 30, 2015 | 240.69M |
| June 30, 2015 | 270.78M |
| March 31, 2015 | 297.89M |
| December 31, 2014 | 322.49M |
| September 30, 2014 | 337.80M |
| June 30, 2014 | 354.45M |
| March 31, 2014 | 369.28M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 238.86M |
| Gilead Sciences, Inc. | 7.952B |
| Ionis Pharmaceuticals, Inc. | 2.055B |
| MannKind Corp. | 111.13M |
| Vertex Pharmaceuticals, Inc. | 7.863B |